Clinical Trials
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Clinical Trials | CRO News | Drug Development
QPS Launches New Brand Identity
Since 1995, QPS has grown from one office headquartered in Delaware to 11 locations globally, and completed seven corporate acquisitions01.15.19
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News | R&D
Clinigen Extends Agreement with Accord Health
The agreement now covers Accord’s European Solid Dose Products, including those in the central nervous system, autoimmune, diabetes and anti-viral therapy areas01.10.19
-
Bio News | Clinical Trials | Industry News | R&D | Trials & Filings
NeuroBo Pharmaceuticals to Initiate Phase 3 Trial
Study will evaluate the efficacy of its lead drug, NB-01, in diabetic neuropathic pain, and is set to start in Q2 of this year01.08.19
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | CRO News | Drug Development
PAREXEL Launches Biotech Division
To support emerging biotech companies in reaching their drug development and commercialization goals01.07.19
-
Bio News | Clinical Trials | Drug Development | Industry News | R&D | Trials & Filings
FDA Grants Mustang Bio ODD
For MB-102 (CD123 CAR T) for the treatment of blastic plasmacytoid dendritic cell neoplasm12.20.18
-
Bio News | Clinical Trials | Industry News | R&D
Neurotrope Announces Publication of Phase 2 Alzheimer's Study
The multidose, exploratory trial was to evaluate Bryostatin-1 as a treatment of cognitive deficits in moderate to severe Alzheimer's disease12.17.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | Laboratory Testing | R&D
Alkermes, Biogen Submit NDA to FDA
For diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis12.17.18
-
Breaking News | Clinical Trials | CRO News | Drug Development | Promotions & Moves
PPD Adds New Therapeutic Area Leaders
Enhances drug development capabilities in cardiovascular disease, critical care, endocrinology, metabolism and diabetes12.13.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
AC Immune & Lilly Partner for Alzheimer's
The license and collaboration agreement is to research and develop tau aggregation inhibitor small molecules for the potential treatment of AD12.12.18
-
Breaking News | Clinical Trials | CRO News | Drug Development
Rho Adds Regulatory Strategy and Submissions Biz
Will support sponsors in planning, developing and submitting marketing applications12.11.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
CBT & Strata Oncology Enter Development Deal
To drive patient enrollment in CBT’s ongoing Phase 1/2 trial of CBT-101 in patients with c-Met dysregulated malignancies including non-small cell lung cancer12.10.18
-
Breaking News | Clinical Trials | Drug Development | Industry News
Eisai, UCL Alliance Advances Alzheimer's Candidate
Phase I trial of E2814, an anti-tau monoclonal antibody, will assess the ability to slow the progression of AD12.07.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Biogen Licenses ALS Treatment from Ionis
Obtained worldwide, exclusive, royalty-bearing license to develop and commercialize BIIB067 (IONIS-SOD1RX)12.06.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D
VBI, Brii Bio Partner for Hepatitis B
Brii Bio paid VBI $11 million upfront, including a $4 million upfront payment & a $7 million equity investment at $3 a share12.06.18
-
Breaking News | Clinical Trials | CRO News
PAREXEL, Lilly to Develop China’s Clinical Research Workforce
Program aims to bring high-value training opportunities to China’s clinical trial sites12.06.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
iDD Biotech Receives Second Milestone
Milstone was initiated after its partner, Genmab, started a Phase I/IIa trial of GEN102912.04.18
-
Breaking News | Clinical Trials | CRO News | Industry News
QPS Expands U.S.-Based Phase I Clinical Trial Services
Supports growing needs of its pharmaceutical, biotech and CRO partners12.03.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
TRACON & I-Mab Partner for Immuno-Oncology
TRACON to be responsible for the regulatory & clinical development of I-Mab's TJD5 & up to five of the BsAbs in North America11.29.18
-
Clinical Trials | Drug Development | GMPs/GCPs | Information Technology
Update on ICH E6 R2 Guideline for GCP
Patrick Hughes of CluePoints discusses opportunities and advantages of the new guidance and considers possible limitationsPatrick Hughes, Chief Commercial Officer, CluePoints 11.27.18
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development
Aileron, Pfizer in Clinical Collaboration
To evaluate the combination of Aileron’s ALRN-6924 and Pfizer’s IBRANCE in cancer11.27.18
